AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results Nearly ...
Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results Nearly ...